T-CURX
T-CURX is a Healthcare & Life Sciences startup based in Germany, most recent round Series A, 2 tracked investors.
About T-CURX
T-CURX is a company headquartered in Germany. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
T-CURX is a German biotechnology company developing non-viral CAR-T cell therapies by delivering Sleeping Beauty transposon vectors to T cells via T cell-targeted lipid nanoparticles to enable stable CAR expression in vivo or bedside-manufactured CAR-T. The company is advancing clinical CAR-T programs targeting indications including AML and CLL as well as targets expressed in both hematological malignancies and solid tumors.
Explore T-CURX's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.